pharma · ADHD · Idiopathic Hypersomnia · ZVRA
ZEVRA THERAPEUTICS
ZEVRA THERAPEUTICS, INC.
ZEVRA THERAPEUTICS is a pharma organization headquartered in Boston, USA. It trades on NYSE under ticker ZVRA. Primary therapeutic focus areas include ADHD, Idiopathic Hypersomnia, Combined D,L-2-hydroxyglutaric Aciduria
Boston, USA HQ
2006 Founded
81 Employees
Public company Type
ZVRA · NYSE Ticker
Company details
- Status
- Public
- HQ
- Boston, USA
- Founded
- 2006
- Employees
- 81
- Programs
- 4
- Drugs
- 6
- Patents
- 5
KP415 oral capsule
Phase 3 · small molecule · ADHD
KP415 oral capsule for ADHD is a Phase 3 program (small_molecule) at ZEVRA THERAPEUTICS, INC. with 2 ClinicalTrials.gov record(s).
Internal code KP415.E01
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- ZEVRA THERAPEUTICS, INC.
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- ADHD
- Status
- completed
- Trials
- 2